<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2004-02-02" modified="2017-11-22" version="161">
<accession>Q96EP1</accession>
<accession>A6NEN5</accession>
<accession>B4DZ77</accession>
<accession>B4E2L6</accession>
<accession>Q96SL3</accession>
<accession>Q9NRT4</accession>
<accession>Q9NT32</accession>
<accession>Q9NVD5</accession>
<name>CHFR_HUMAN</name>
<protein>
<recommendedName>
<fullName>E3 ubiquitin-protein ligase CHFR</fullName>
<ecNumber evidence="10 11 13 20 21">2.3.2.27</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Checkpoint with forkhead and RING finger domains protein</fullName>
</alternativeName>
<alternativeName>
<fullName>RING finger protein 196</fullName>
</alternativeName>
<alternativeName>
<fullName evidence="24">RING-type E3 ubiquitin transferase CHFR</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">CHFR</name>
<name type="synonym">RNF196</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2000" name="Nature" volume="406" first="430" last="435">
<title>Chfr defines a mitotic stress checkpoint that delays entry into metaphase.</title>
<authorList>
<person name="Scolnick D.M."/>
<person name="Halazonetis T.D."/>
</authorList>
<dbReference type="PubMed" id="10935642"/>
<dbReference type="DOI" id="10.1038/35019108"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>VARIANT MET-580</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2; 3 AND 4)</scope>
<scope>VARIANT MET-580</scope>
<source>
<tissue>Teratocarcinoma</tissue>
<tissue>Testis</tissue>
<tissue>Trachea</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2006" name="Nature" volume="440" first="346" last="351">
<title>The finished DNA sequence of human chromosome 12.</title>
<authorList>
<person name="Scherer S.E."/>
<person name="Muzny D.M."/>
<person name="Buhay C.J."/>
<person name="Chen R."/>
<person name="Cree A."/>
<person name="Ding Y."/>
<person name="Dugan-Rocha S."/>
<person name="Gill R."/>
<person name="Gunaratne P."/>
<person name="Harris R.A."/>
<person name="Hawes A.C."/>
<person name="Hernandez J."/>
<person name="Hodgson A.V."/>
<person name="Hume J."/>
<person name="Jackson A."/>
<person name="Khan Z.M."/>
<person name="Kovar-Smith C."/>
<person name="Lewis L.R."/>
<person name="Lozado R.J."/>
<person name="Metzker M.L."/>
<person name="Milosavljevic A."/>
<person name="Miner G.R."/>
<person name="Montgomery K.T."/>
<person name="Morgan M.B."/>
<person name="Nazareth L.V."/>
<person name="Scott G."/>
<person name="Sodergren E."/>
<person name="Song X.-Z."/>
<person name="Steffen D."/>
<person name="Lovering R.C."/>
<person name="Wheeler D.A."/>
<person name="Worley K.C."/>
<person name="Yuan Y."/>
<person name="Zhang Z."/>
<person name="Adams C.Q."/>
<person name="Ansari-Lari M.A."/>
<person name="Ayele M."/>
<person name="Brown M.J."/>
<person name="Chen G."/>
<person name="Chen Z."/>
<person name="Clerc-Blankenburg K.P."/>
<person name="Davis C."/>
<person name="Delgado O."/>
<person name="Dinh H.H."/>
<person name="Draper H."/>
<person name="Gonzalez-Garay M.L."/>
<person name="Havlak P."/>
<person name="Jackson L.R."/>
<person name="Jacob L.S."/>
<person name="Kelly S.H."/>
<person name="Li L."/>
<person name="Li Z."/>
<person name="Liu J."/>
<person name="Liu W."/>
<person name="Lu J."/>
<person name="Maheshwari M."/>
<person name="Nguyen B.-V."/>
<person name="Okwuonu G.O."/>
<person name="Pasternak S."/>
<person name="Perez L.M."/>
<person name="Plopper F.J.H."/>
<person name="Santibanez J."/>
<person name="Shen H."/>
<person name="Tabor P.E."/>
<person name="Verduzco D."/>
<person name="Waldron L."/>
<person name="Wang Q."/>
<person name="Williams G.A."/>
<person name="Zhang J."/>
<person name="Zhou J."/>
<person name="Allen C.C."/>
<person name="Amin A.G."/>
<person name="Anyalebechi V."/>
<person name="Bailey M."/>
<person name="Barbaria J.A."/>
<person name="Bimage K.E."/>
<person name="Bryant N.P."/>
<person name="Burch P.E."/>
<person name="Burkett C.E."/>
<person name="Burrell K.L."/>
<person name="Calderon E."/>
<person name="Cardenas V."/>
<person name="Carter K."/>
<person name="Casias K."/>
<person name="Cavazos I."/>
<person name="Cavazos S.R."/>
<person name="Ceasar H."/>
<person name="Chacko J."/>
<person name="Chan S.N."/>
<person name="Chavez D."/>
<person name="Christopoulos C."/>
<person name="Chu J."/>
<person name="Cockrell R."/>
<person name="Cox C.D."/>
<person name="Dang M."/>
<person name="Dathorne S.R."/>
<person name="David R."/>
<person name="Davis C.M."/>
<person name="Davy-Carroll L."/>
<person name="Deshazo D.R."/>
<person name="Donlin J.E."/>
<person name="D'Souza L."/>
<person name="Eaves K.A."/>
<person name="Egan A."/>
<person name="Emery-Cohen A.J."/>
<person name="Escotto M."/>
<person name="Flagg N."/>
<person name="Forbes L.D."/>
<person name="Gabisi A.M."/>
<person name="Garza M."/>
<person name="Hamilton C."/>
<person name="Henderson N."/>
<person name="Hernandez O."/>
<person name="Hines S."/>
<person name="Hogues M.E."/>
<person name="Huang M."/>
<person name="Idlebird D.G."/>
<person name="Johnson R."/>
<person name="Jolivet A."/>
<person name="Jones S."/>
<person name="Kagan R."/>
<person name="King L.M."/>
<person name="Leal B."/>
<person name="Lebow H."/>
<person name="Lee S."/>
<person name="LeVan J.M."/>
<person name="Lewis L.C."/>
<person name="London P."/>
<person name="Lorensuhewa L.M."/>
<person name="Loulseged H."/>
<person name="Lovett D.A."/>
<person name="Lucier A."/>
<person name="Lucier R.L."/>
<person name="Ma J."/>
<person name="Madu R.C."/>
<person name="Mapua P."/>
<person name="Martindale A.D."/>
<person name="Martinez E."/>
<person name="Massey E."/>
<person name="Mawhiney S."/>
<person name="Meador M.G."/>
<person name="Mendez S."/>
<person name="Mercado C."/>
<person name="Mercado I.C."/>
<person name="Merritt C.E."/>
<person name="Miner Z.L."/>
<person name="Minja E."/>
<person name="Mitchell T."/>
<person name="Mohabbat F."/>
<person name="Mohabbat K."/>
<person name="Montgomery B."/>
<person name="Moore N."/>
<person name="Morris S."/>
<person name="Munidasa M."/>
<person name="Ngo R.N."/>
<person name="Nguyen N.B."/>
<person name="Nickerson E."/>
<person name="Nwaokelemeh O.O."/>
<person name="Nwokenkwo S."/>
<person name="Obregon M."/>
<person name="Oguh M."/>
<person name="Oragunye N."/>
<person name="Oviedo R.J."/>
<person name="Parish B.J."/>
<person name="Parker D.N."/>
<person name="Parrish J."/>
<person name="Parks K.L."/>
<person name="Paul H.A."/>
<person name="Payton B.A."/>
<person name="Perez A."/>
<person name="Perrin W."/>
<person name="Pickens A."/>
<person name="Primus E.L."/>
<person name="Pu L.-L."/>
<person name="Puazo M."/>
<person name="Quiles M.M."/>
<person name="Quiroz J.B."/>
<person name="Rabata D."/>
<person name="Reeves K."/>
<person name="Ruiz S.J."/>
<person name="Shao H."/>
<person name="Sisson I."/>
<person name="Sonaike T."/>
<person name="Sorelle R.P."/>
<person name="Sutton A.E."/>
<person name="Svatek A.F."/>
<person name="Svetz L.A."/>
<person name="Tamerisa K.S."/>
<person name="Taylor T.R."/>
<person name="Teague B."/>
<person name="Thomas N."/>
<person name="Thorn R.D."/>
<person name="Trejos Z.Y."/>
<person name="Trevino B.K."/>
<person name="Ukegbu O.N."/>
<person name="Urban J.B."/>
<person name="Vasquez L.I."/>
<person name="Vera V.A."/>
<person name="Villasana D.M."/>
<person name="Wang L."/>
<person name="Ward-Moore S."/>
<person name="Warren J.T."/>
<person name="Wei X."/>
<person name="White F."/>
<person name="Williamson A.L."/>
<person name="Wleczyk R."/>
<person name="Wooden H.S."/>
<person name="Wooden S.H."/>
<person name="Yen J."/>
<person name="Yoon L."/>
<person name="Yoon V."/>
<person name="Zorrilla S.E."/>
<person name="Nelson D."/>
<person name="Kucherlapati R."/>
<person name="Weinstock G."/>
<person name="Gibbs R.A."/>
</authorList>
<dbReference type="PubMed" id="16541075"/>
<dbReference type="DOI" id="10.1038/nature04569"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<scope>VARIANT VAL-497</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2007" name="BMC Genomics" volume="8" first="399" last="399">
<title>The full-ORF clone resource of the German cDNA consortium.</title>
<authorList>
<person name="Bechtel S."/>
<person name="Rosenfelder H."/>
<person name="Duda A."/>
<person name="Schmidt C.P."/>
<person name="Ernst U."/>
<person name="Wellenreuther R."/>
<person name="Mehrle A."/>
<person name="Schuster C."/>
<person name="Bahr A."/>
<person name="Bloecker H."/>
<person name="Heubner D."/>
<person name="Hoerlein A."/>
<person name="Michel G."/>
<person name="Wedler H."/>
<person name="Koehrer K."/>
<person name="Ottenwaelder B."/>
<person name="Poustka A."/>
<person name="Wiemann S."/>
<person name="Schupp I."/>
</authorList>
<dbReference type="PubMed" id="17974005"/>
<dbReference type="DOI" id="10.1186/1471-2164-8-399"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 359-664</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2002" name="J. Cell Biol." volume="156" first="249" last="259">
<title>The checkpoint protein Chfr is a ligase that ubiquitinates Plk1 and inhibits Cdc2 at the G2 to M transition.</title>
<authorList>
<person name="Kang D."/>
<person name="Chen J."/>
<person name="Wong J."/>
<person name="Fang G."/>
</authorList>
<dbReference type="PubMed" id="11807090"/>
<dbReference type="DOI" id="10.1083/jcb.200108016"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>AUTOUBIQUITINATION</scope>
<scope>MUTAGENESIS OF ILE-306 AND TRP-332</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2002" name="Cancer Res." volume="62" first="1797" last="1801">
<title>Chfr regulates a mitotic stress pathway through its RING-finger domain with ubiquitin ligase activity.</title>
<authorList>
<person name="Chaturvedi P."/>
<person name="Sudakin V."/>
<person name="Bobiak M.L."/>
<person name="Fisher P.W."/>
<person name="Mattern M.R."/>
<person name="Jablonski S.A."/>
<person name="Hurle M.R."/>
<person name="Zhu Y."/>
<person name="Yen T.J."/>
<person name="Zhou B.-B."/>
</authorList>
<dbReference type="PubMed" id="11912157"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>AUTOUBIQUITINATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>DEVELOPMENTAL STAGE</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-244</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="2002" name="Oncogene" volume="21" first="2328" last="2333">
<title>Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers.</title>
<authorList>
<person name="Mizuno K."/>
<person name="Osada H."/>
<person name="Konishi H."/>
<person name="Tatematsu Y."/>
<person name="Yatabe Y."/>
<person name="Mitsudomi T."/>
<person name="Fujii Y."/>
<person name="Takahashi T."/>
</authorList>
<dbReference type="PubMed" id="11948416"/>
<dbReference type="DOI" id="10.1038/sj.onc.1205402"/>
</citation>
<scope>VARIANTS ARG-270; VAL-497 AND MET-580</scope>
<scope>SILENCING IN PRIMARY CANCERS</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2003" name="Carcinogenesis" volume="24" first="47" last="51">
<title>Frequent hypermethylation of the 5' CpG island of the mitotic stress checkpoint gene Chfr in colorectal and non-small cell lung cancer.</title>
<authorList>
<person name="Corn P.G."/>
<person name="Summers M.K."/>
<person name="Fogt F."/>
<person name="Virmani A.K."/>
<person name="Gazdar A.F."/>
<person name="Halazonetis T.D."/>
<person name="El-Deiry W.S."/>
</authorList>
<dbReference type="PubMed" id="12538348"/>
<dbReference type="DOI" id="10.1093/carcin/24.1.47"/>
</citation>
<scope>SILENCING IN PRIMARY CANCERS</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2003" name="Proc. Natl. Acad. Sci. U.S.A." volume="100" first="7818" last="7823">
<title>Epigenetic inactivation of CHFR in human tumors.</title>
<authorList>
<person name="Toyota M."/>
<person name="Sasaki Y."/>
<person name="Satoh A."/>
<person name="Ogi K."/>
<person name="Kikuchi T."/>
<person name="Suzuki H."/>
<person name="Mita H."/>
<person name="Tanaka N."/>
<person name="Itoh F."/>
<person name="Issa J.-P.J."/>
<person name="Jair K.-W."/>
<person name="Schuebel K.E."/>
<person name="Imai K."/>
<person name="Tokino T."/>
</authorList>
<dbReference type="PubMed" id="12810945"/>
<dbReference type="DOI" id="10.1073/pnas.1337066100"/>
</citation>
<scope>SILENCING IN PRIMARY CANCERS</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2003" name="Cancer Res." volume="63" first="8606" last="8613">
<title>Epigenetic inactivation of CHFR and sensitivity to microtubule inhibitors in gastric cancer.</title>
<authorList>
<person name="Satoh A."/>
<person name="Toyota M."/>
<person name="Itoh F."/>
<person name="Sasaki Y."/>
<person name="Suzuki H."/>
<person name="Ogi K."/>
<person name="Kikuchi T."/>
<person name="Mita H."/>
<person name="Yamashita T."/>
<person name="Kojima T."/>
<person name="Kusano M."/>
<person name="Fujita M."/>
<person name="Hosokawa M."/>
<person name="Endo T."/>
<person name="Tokino T."/>
<person name="Imai K."/>
</authorList>
<dbReference type="PubMed" id="14695171"/>
</citation>
<scope>SILENCING IN PRIMARY CANCERS</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2003" name="Mol. Cancer Res." volume="1" first="959" last="969">
<title>Promotion of mitosis by activated protein kinase B after DNA damage involves polo-like kinase 1 and checkpoint protein CHFR.</title>
<authorList>
<person name="Shtivelman E."/>
</authorList>
<dbReference type="PubMed" id="14638868"/>
</citation>
<scope>PHOSPHORYLATION</scope>
<scope>MUTAGENESIS OF THR-39 AND SER-205</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2003" name="Oncogene" volume="22" first="7101" last="7107">
<title>The Chfr mitotic checkpoint protein functions with Ubc13-Mms2 to form Lys63-linked polyubiquitin chains.</title>
<authorList>
<person name="Bothos J."/>
<person name="Summers M.K."/>
<person name="Venere M."/>
<person name="Scolnick D.M."/>
<person name="Halazonetis T.D."/>
</authorList>
<dbReference type="PubMed" id="14562038"/>
<dbReference type="DOI" id="10.1038/sj.onc.1206831"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>INTERACTION WITH UBE2V2</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2004" name="Mol. Carcinog." volume="39" first="26" last="33">
<title>CHFR-associated early G2/M checkpoint defects in breast cancer cells.</title>
<authorList>
<person name="Erson A.E."/>
<person name="Petty E.M."/>
</authorList>
<dbReference type="PubMed" id="14694445"/>
<dbReference type="DOI" id="10.1002/mc.10161"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2004" name="Nat. Struct. Mol. Biol." volume="11" first="1114" last="1121">
<title>PML bodies control the nuclear dynamics and function of the CHFR mitotic checkpoint protein.</title>
<authorList>
<person name="Daniels M.J."/>
<person name="Marson A."/>
<person name="Venkitaraman A.R."/>
</authorList>
<dbReference type="PubMed" id="15467728"/>
<dbReference type="DOI" id="10.1038/nsmb837"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH PML</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2008" name="Nature" volume="451" first="81" last="85">
<title>Poly(ADP-ribose)-binding zinc finger motifs in DNA repair/checkpoint proteins.</title>
<authorList>
<person name="Ahel I."/>
<person name="Ahel D."/>
<person name="Matsusaka T."/>
<person name="Clark A.J."/>
<person name="Pines J."/>
<person name="Boulton S.J."/>
<person name="West S.C."/>
</authorList>
<dbReference type="PubMed" id="18172500"/>
<dbReference type="DOI" id="10.1038/nature06420"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>DOMAIN PBZ-TYPE</scope>
<scope>POLY-ADP-RIBOSYLATION</scope>
<scope>ADP-RIBOSE-BINDING</scope>
<scope>MUTAGENESIS OF ARG-632; CYS-635; CYS-641; ARG-642 AND GLN-644</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2008" name="PLoS ONE" volume="3" first="E1776" last="E1776">
<title>The anti-proliferative effects of the CHFR depend on the forkhead associated domain, but not E3 ligase activity mediated by ring finger domain.</title>
<authorList>
<person name="Fukuda T."/>
<person name="Kondo Y."/>
<person name="Nakagama H."/>
</authorList>
<dbReference type="PubMed" id="18335050"/>
<dbReference type="DOI" id="10.1371/journal.pone.0001776"/>
</citation>
<scope>DOMAIN FHA</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2009" name="Nat. Cell Biol." volume="11" first="295" last="302">
<title>Chfr is linked to tumour metastasis through the downregulation of HDAC1.</title>
<authorList>
<person name="Oh Y.M."/>
<person name="Kwon Y.E."/>
<person name="Kim J.M."/>
<person name="Bae S.J."/>
<person name="Lee B.K."/>
<person name="Yoo S.J."/>
<person name="Chung C.H."/>
<person name="Deshaies R.J."/>
<person name="Seol J.H."/>
</authorList>
<dbReference type="PubMed" id="19182791"/>
<dbReference type="DOI" id="10.1038/ncb1837"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>INTERACTION WITH HDAC1 AND HDAC2</scope>
<scope>AUTOUBIQUITINATION</scope>
<scope>MUTAGENESIS OF ILE-306</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2002" name="Structure" volume="10" first="891" last="899">
<title>Crystal structure of the FHA domain of the Chfr mitotic checkpoint protein and its complex with tungstate.</title>
<authorList>
<person name="Stavridi E.S."/>
<person name="Huyen Y."/>
<person name="Loreto I.R."/>
<person name="Scolnick D.M."/>
<person name="Halazonetis T.D."/>
<person name="Pavletich N.P."/>
<person name="Jeffrey P.D."/>
</authorList>
<dbReference type="PubMed" id="12121644"/>
<dbReference type="DOI" id="10.1016/S0969-2126(02)00776-1"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 14-128</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2003" name="Cancer Res." volume="63" first="7185" last="7189">
<title>Inactivating mutations targeting the chfr mitotic checkpoint gene in human lung cancer.</title>
<authorList>
<person name="Mariatos G."/>
<person name="Bothos J."/>
<person name="Zacharatos P."/>
<person name="Summers M.K."/>
<person name="Scolnick D.M."/>
<person name="Kittas C."/>
<person name="Halazonetis T.D."/>
<person name="Gorgoulis V.G."/>
</authorList>
<dbReference type="PubMed" id="14612512"/>
</citation>
<scope>VARIANTS LEU-166; PRO-202 AND SER-536</scope>
</reference>
<comment type="function">
<text evidence="9 10 11 13 16 20 21">E3 ubiquitin-protein ligase that functions in the antephase checkpoint by actively delaying passage into mitosis in response to microtubule poisons. Acts in early prophase before chromosome condensation, when the centrosome move apart from each other along the periphery of the nucleus. Probably involved in signaling the presence of mitotic stress caused by microtubule poisons by mediating the 'Lys-48'-linked ubiquitination of target proteins, leading to their degradation by the proteasome. Promotes the ubiquitination and subsequent degradation of AURKA and PLK1. Probably acts as a tumor suppressor, possibly by mediating the polyubiquitination of HDAC1, leading to its degradation. May also promote the formation of 'Lys-63'-linked polyubiquitin chains and functions with the specific ubiquitin-conjugating UBC13-MMS2 (UBE2N-UBE2V2) heterodimer. Substrates that are polyubiquitinated at 'Lys-63' are usually not targeted for degradation, but are rather involved in signaling cellular stress.</text>
</comment>
<comment type="catalytic activity">
<text evidence="10 11 13 20 21">S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.</text>
</comment>
<comment type="pathway">
<text>Protein modification; protein ubiquitination.</text>
</comment>
<comment type="subunit">
<text evidence="13 18 21">Interacts with HDAC1 and HDAC2. Interacts with PML (with sumoylated form of PML).</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="11 18 20">Nucleus</location>
<location evidence="11 18 20">PML body</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q96EP1-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q96EP1-2</id>
<name>2</name>
<sequence type="described" ref="VSP_009349"/>
</isoform>
<isoform>
<id>Q96EP1-3</id>
<name>3</name>
<sequence type="described" ref="VSP_009350"/>
</isoform>
<isoform>
<id>Q96EP1-4</id>
<name>4</name>
<sequence type="described" ref="VSP_038127"/>
</isoform>
<isoform>
<id>Q96EP1-5</id>
<name>5</name>
<sequence type="described" ref="VSP_038126"/>
<text>No experimental confirmation available.</text>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="9">Ubiquitous.</text>
</comment>
<comment type="developmental stage">
<text evidence="11">Weakly expressed in G1 phase, and highly expressed during S phase.</text>
</comment>
<comment type="domain">
<text>The PBZ-type zinc finger (also named CYR) mediates non-covalent poly(ADP-ribose)-binding. Poly(ADP-ribose)-binding is dependent on the presence of zinc and is required for its function in antephase checkpoint.</text>
</comment>
<comment type="domain">
<text>The FHA domain plays a key role in the anti-proliferative properties of the protein and is involved in initiating a cell cycle arrest at G2/M. The FHA domain may be required to interact with phosphorylated proteins.</text>
</comment>
<comment type="PTM">
<text>Poly-ADP-ribosylated. In addition to binding non covalently poly(ADP-ribose) via its PBZ-type zinc finger, the protein is also covalently poly-ADP-ribosylated by PARP1.</text>
</comment>
<comment type="PTM">
<text evidence="10 11 21">Autoubiquitinated; may regulate its cellular level.</text>
</comment>
<comment type="PTM">
<text evidence="13 15">Phosphorylated by PKB. Phosphorylation may affect its E3 ligase activity.</text>
</comment>
<comment type="miscellaneous">
<text>CHFR is silenced in many primary cancers because of CpG methylation and deacetylated histones on its promoter region. This however raises the question of whether CHFR silencing is a consequence or a cause of primary cancers.</text>
</comment>
<comment type="similarity">
<text evidence="24">Belongs to the CHFR family.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/CHFRID526.html"/>
</comment>
<dbReference type="EC" id="2.3.2.27" evidence="10 11 13 20 21"/>
<dbReference type="EMBL" id="AF170724">
<property type="protein sequence ID" value="AAF91084.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK001658">
<property type="protein sequence ID" value="BAA91817.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK027687">
<property type="protein sequence ID" value="BAB55297.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK302785">
<property type="protein sequence ID" value="BAG63989.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK304333">
<property type="protein sequence ID" value="BAG65178.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC127070">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC012072">
<property type="protein sequence ID" value="AAH12072.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL137561">
<property type="protein sequence ID" value="CAB70812.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS31937.1">
<molecule id="Q96EP1-3"/>
</dbReference>
<dbReference type="CCDS" id="CCDS53847.1">
<molecule id="Q96EP1-5"/>
</dbReference>
<dbReference type="CCDS" id="CCDS53848.1">
<molecule id="Q96EP1-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS53849.1">
<molecule id="Q96EP1-1"/>
</dbReference>
<dbReference type="PIR" id="T46399">
<property type="entry name" value="T46399"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001154816.1">
<molecule id="Q96EP1-1"/>
<property type="nucleotide sequence ID" value="NM_001161344.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001154817.1">
<molecule id="Q96EP1-4"/>
<property type="nucleotide sequence ID" value="NM_001161345.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001154818.1">
<molecule id="Q96EP1-2"/>
<property type="nucleotide sequence ID" value="NM_001161346.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001154819.1">
<molecule id="Q96EP1-5"/>
<property type="nucleotide sequence ID" value="NM_001161347.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_060693.2">
<molecule id="Q96EP1-3"/>
<property type="nucleotide sequence ID" value="NM_018223.2"/>
</dbReference>
<dbReference type="UniGene" id="Hs.720197"/>
<dbReference type="PDB" id="1LGP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=14-128"/>
</dbReference>
<dbReference type="PDB" id="1LGQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A/B=14-124"/>
</dbReference>
<dbReference type="PDB" id="2XOC">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.89"/>
<property type="chains" value="A/B=407-664"/>
</dbReference>
<dbReference type="PDB" id="2XOY">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/B=407-664"/>
</dbReference>
<dbReference type="PDB" id="2XOZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.37"/>
<property type="chains" value="A/B=407-664"/>
</dbReference>
<dbReference type="PDB" id="2XP0">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.98"/>
<property type="chains" value="A/B=394-664"/>
</dbReference>
<dbReference type="PDBsum" id="1LGP"/>
<dbReference type="PDBsum" id="1LGQ"/>
<dbReference type="PDBsum" id="2XOC"/>
<dbReference type="PDBsum" id="2XOY"/>
<dbReference type="PDBsum" id="2XOZ"/>
<dbReference type="PDBsum" id="2XP0"/>
<dbReference type="ProteinModelPortal" id="Q96EP1"/>
<dbReference type="SMR" id="Q96EP1"/>
<dbReference type="BioGrid" id="120861">
<property type="interactions" value="46"/>
</dbReference>
<dbReference type="DIP" id="DIP-40098N"/>
<dbReference type="IntAct" id="Q96EP1">
<property type="interactions" value="20"/>
</dbReference>
<dbReference type="MINT" id="MINT-1381330"/>
<dbReference type="STRING" id="9606.ENSP00000392395"/>
<dbReference type="iPTMnet" id="Q96EP1"/>
<dbReference type="PhosphoSitePlus" id="Q96EP1"/>
<dbReference type="BioMuta" id="CHFR"/>
<dbReference type="DMDM" id="41688511"/>
<dbReference type="EPD" id="Q96EP1"/>
<dbReference type="MaxQB" id="Q96EP1"/>
<dbReference type="PaxDb" id="Q96EP1"/>
<dbReference type="PeptideAtlas" id="Q96EP1"/>
<dbReference type="PRIDE" id="Q96EP1"/>
<dbReference type="DNASU" id="55743"/>
<dbReference type="Ensembl" id="ENST00000266880">
<molecule id="Q96EP1-3"/>
<property type="protein sequence ID" value="ENSP00000266880"/>
<property type="gene ID" value="ENSG00000072609"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000432561">
<molecule id="Q96EP1-1"/>
<property type="protein sequence ID" value="ENSP00000392395"/>
<property type="gene ID" value="ENSG00000072609"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000443047">
<molecule id="Q96EP1-5"/>
<property type="protein sequence ID" value="ENSP00000416431"/>
<property type="gene ID" value="ENSG00000072609"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000450056">
<molecule id="Q96EP1-2"/>
<property type="protein sequence ID" value="ENSP00000398735"/>
<property type="gene ID" value="ENSG00000072609"/>
</dbReference>
<dbReference type="GeneID" id="55743"/>
<dbReference type="KEGG" id="hsa:55743"/>
<dbReference type="UCSC" id="uc001uld.3">
<molecule id="Q96EP1-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="55743"/>
<dbReference type="DisGeNET" id="55743"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000072609.17"/>
<dbReference type="GeneCards" id="CHFR"/>
<dbReference type="HGNC" id="HGNC:20455">
<property type="gene designation" value="CHFR"/>
</dbReference>
<dbReference type="HPA" id="HPA045768"/>
<dbReference type="MIM" id="605209">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q96EP1"/>
<dbReference type="OpenTargets" id="ENSG00000072609"/>
<dbReference type="PharmGKB" id="PA134898949"/>
<dbReference type="eggNOG" id="KOG0802">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG5243">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00400000022306"/>
<dbReference type="HOVERGEN" id="HBG048005"/>
<dbReference type="InParanoid" id="Q96EP1"/>
<dbReference type="KO" id="K10644"/>
<dbReference type="OMA" id="HLYWGCA"/>
<dbReference type="OrthoDB" id="EOG091G03AR"/>
<dbReference type="PhylomeDB" id="Q96EP1"/>
<dbReference type="TreeFam" id="TF330957"/>
<dbReference type="UniPathway" id="UPA00143"/>
<dbReference type="ChiTaRS" id="CHFR">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q96EP1"/>
<dbReference type="GeneWiki" id="CHFR"/>
<dbReference type="GenomeRNAi" id="55743"/>
<dbReference type="PRO" id="PR:Q96EP1"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 12"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000072609"/>
<dbReference type="CleanEx" id="HS_CHFR"/>
<dbReference type="ExpressionAtlas" id="Q96EP1">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q96EP1">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016605">
<property type="term" value="C:PML body"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0000166">
<property type="term" value="F:nucleotide binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0061630">
<property type="term" value="F:ubiquitin protein ligase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0004842">
<property type="term" value="F:ubiquitin-protein transferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051301">
<property type="term" value="P:cell division"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0007093">
<property type="term" value="P:mitotic cell cycle checkpoint"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019941">
<property type="term" value="P:modification-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032436">
<property type="term" value="P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031398">
<property type="term" value="P:positive regulation of protein ubiquitination"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031648">
<property type="term" value="P:protein destabilization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000209">
<property type="term" value="P:protein polyubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006511">
<property type="term" value="P:ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="CDD" id="cd00060">
<property type="entry name" value="FHA"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.40.10">
<property type="match status" value="2"/>
</dbReference>
<dbReference type="InterPro" id="IPR000253">
<property type="entry name" value="FHA_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR008984">
<property type="entry name" value="SMAD_FHA_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR001841">
<property type="entry name" value="Znf_RING"/>
</dbReference>
<dbReference type="InterPro" id="IPR013083">
<property type="entry name" value="Znf_RING/FYVE/PHD"/>
</dbReference>
<dbReference type="InterPro" id="IPR017907">
<property type="entry name" value="Znf_RING_CS"/>
</dbReference>
<dbReference type="Pfam" id="PF00498">
<property type="entry name" value="FHA"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00240">
<property type="entry name" value="FHA"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00184">
<property type="entry name" value="RING"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF49879">
<property type="entry name" value="SSF49879"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50006">
<property type="entry name" value="FHA_DOMAIN"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00518">
<property type="entry name" value="ZF_RING_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50089">
<property type="entry name" value="ZF_RING_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0013">ADP-ribosylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0131">Cell cycle</keyword>
<keyword id="KW-0132">Cell division</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0498">Mitosis</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0833">Ubl conjugation pathway</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="chain" description="E3 ubiquitin-protein ligase CHFR" id="PRO_0000055872">
<location>
<begin position="1"/>
<end position="664"/>
</location>
</feature>
<feature type="domain" description="FHA" evidence="7">
<location>
<begin position="38"/>
<end position="89"/>
</location>
</feature>
<feature type="zinc finger region" description="RING-type" evidence="8">
<location>
<begin position="304"/>
<end position="343"/>
</location>
</feature>
<feature type="zinc finger region" description="PBZ-type">
<location>
<begin position="633"/>
<end position="655"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5">
<location>
<position position="244"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="6">
<location>
<position position="386"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_038126" evidence="24">
<original>NVAYLYESLSEKQGMTQESFEANKENVFHGTKDTSGAGAGRGADPRVPPSSPATQVCFEEPQPSTSTSDLFPTASASSTEPSPAGRERSSSCG</original>
<variation>R</variation>
<location>
<begin position="115"/>
<end position="207"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_009349" evidence="22 23">
<location>
<begin position="135"/>
<end position="146"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_009350" evidence="22">
<original>ANKENVFHGTKDTSGAGAGRGADPRVPPSSPATQVCFEEPQPSTSTSDLFPTASASSTEPSPAGRERSSSC</original>
<variation>MVPCCVAQAGLKLLGSSDPPTLASQSIVIT</variation>
<location>
<begin position="136"/>
<end position="206"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_038127" evidence="22">
<location>
<position position="470"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with non small cell lung carcinomas; homozygous." id="VAR_017582" evidence="14">
<original>P</original>
<variation>L</variation>
<location>
<position position="166"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with non small cell lung carcinomas." id="VAR_017583" evidence="14">
<original>R</original>
<variation>P</variation>
<location>
<position position="202"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs115096950." id="VAR_017584" evidence="12">
<original>G</original>
<variation>R</variation>
<location>
<position position="270"/>
</location>
</feature>
<feature type="sequence variant" description="Common polymorphism; dbSNP:rs2306541." id="VAR_017585" evidence="12 19">
<original>A</original>
<variation>V</variation>
<location>
<position position="497"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with non small cell lung carcinomas." id="VAR_017586" evidence="14">
<original>F</original>
<variation>S</variation>
<location>
<position position="536"/>
</location>
</feature>
<feature type="sequence variant" description="Common polymorphism; dbSNP:rs2306536." id="VAR_017587" evidence="9 12 17">
<original>V</original>
<variation>M</variation>
<location>
<position position="580"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phosphorylation but not autoubiquitination; when associated with A-205." evidence="15">
<original>T</original>
<variation>A</variation>
<location>
<position position="39"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phosphorylation but not autoubiquitination; when associated with A-39." evidence="15">
<original>S</original>
<variation>A</variation>
<location>
<position position="205"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes autoubiquitination. Does not affect phosphorylation." evidence="10 21">
<original>I</original>
<variation>A</variation>
<location>
<position position="306"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes autoubiquitination in vitro." evidence="10">
<original>W</original>
<variation>A</variation>
<location>
<position position="332"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes poly(ADP-ribose)-binding and poly-ADP-ribosylation by PARP1." evidence="20">
<original>R</original>
<variation>A</variation>
<location>
<position position="632"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes poly(ADP-ribose)-binding and poly-ADP-ribosylation by PARP1; when associated with A-641." evidence="20">
<original>C</original>
<variation>A</variation>
<location>
<position position="635"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes poly(ADP-ribose)-binding and poly-ADP-ribosylation by PARP1; when associated with A-635." evidence="20">
<original>C</original>
<variation>A</variation>
<location>
<position position="641"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs poly(ADP-ribose)-binding and poly-ADP-ribosylation by PARP1." evidence="20">
<original>R</original>
<variation>A</variation>
<location>
<position position="642"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs poly(ADP-ribose)-binding and poly-ADP-ribosylation by PARP1." evidence="20">
<original>Q</original>
<variation>A</variation>
<location>
<position position="644"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; BAA91817." ref="2" evidence="24">
<original>V</original>
<variation>E</variation>
<location>
<position position="256"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; BAA91817." ref="2" evidence="24">
<original>S</original>
<variation>P</variation>
<location>
<position position="462"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; BAG65178." ref="2" evidence="24">
<original>V</original>
<variation>A</variation>
<location>
<position position="599"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; BAA91817." ref="2" evidence="24">
<original>R</original>
<variation>Q</variation>
<location>
<position position="617"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="17"/>
<end position="19"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="26"/>
<end position="28"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="31"/>
<end position="33"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="35"/>
<end position="43"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="46"/>
<end position="49"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="61"/>
<end position="65"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="67"/>
<end position="69"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="72"/>
<end position="76"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="78"/>
<end position="80"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="82"/>
<end position="90"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="92"/>
<end position="96"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="102"/>
<end position="106"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="112"/>
<end position="114"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="116"/>
<end position="119"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="433"/>
<end position="436"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="482"/>
<end position="484"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="486"/>
<end position="488"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="491"/>
<end position="493"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="496"/>
<end position="500"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="511"/>
<end position="513"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="519"/>
<end position="522"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="532"/>
<end position="535"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="536"/>
<end position="538"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="543"/>
<end position="552"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="554"/>
<end position="566"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="571"/>
<end position="583"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="599"/>
<end position="601"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="602"/>
<end position="618"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="622"/>
<end position="624"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="627"/>
<end position="630"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="638"/>
<end position="640"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="643"/>
<end position="645"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="647"/>
<end position="652"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1LGP"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1LGQ"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2XOC"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2XP0"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q810L3"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00086"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00175"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10935642"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11807090"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11912157"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11948416"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14562038"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14612512"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14638868"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14694445"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15467728"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18172500"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19182791"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000305"/>
<sequence length="664" mass="73386" checksum="141A1E7FEFAE36A2" modified="2004-02-02" version="2">
MERPEEGKQSPPPQPWGRLLRLGAEEGEPHVLLRKREWTIGRRRGCDLSFPSNKLVSGDH
CRIVVDEKSGQVTLEDTSTSGTVINKLKVVKKQTCPLQTGDVIYLVYRKNEPEHNVAYLY
ESLSEKQGMTQESFEANKENVFHGTKDTSGAGAGRGADPRVPPSSPATQVCFEEPQPSTS
TSDLFPTASASSTEPSPAGRERSSSCGSGGGGISPKGSGPSVASDEVSSFASALPDRKTA
SFSSLEPQDQEDLEPVKKKMRGDGDLDLNGQLLVAQPRRNAQTVHEDVRAAAGKPDKMEE
TLTCIICQDLLHDCVSLQPCMHTFCAACYSGWMERSSLCPTCRCPVERICKNHILNNLVE
AYLIQHPDKSRSEEDVQSMDARNKITQDMLQPKVRRSFSDEEGSSEDLLELSDVDSESSD
ISQPYVVCRQCPEYRRQAAQPPHCPAPEGEPGAPQALGDAPSTSVSLTTAVQDYVCPLQG
SHALCTCCFQPMPDRRAEREQDPRVAPQQCAVCLQPFCHLYWGCTRTGCYGCLAPFCELN
LGDKCLDGVLNNNSYESDILKNYLATRGLTWKNMLTESLVALQRGVFLLSDYRVTGDTVL
CYCCGLRSFRELTYQYRQNIPASELPVAVTSRPDCYWGRNCRTQVKAHHAMKFNHICEQT
RFKN
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>